Two new full-length publications

Veröffentlicht am January 30, 2017 in News

The results of both the BRd study and the Treosulfan study have been issued:

  • The full-length article on the results of the BRd study has been published in the British Journal of Haematology. (Bendamustine, lenalidomide and dexamethasone has high activity as 2nd -line therapy for relapsed and refractory multiple myeloma – a phase II trial)
  • The results of the Treosulfan study have been published in the Journal of Cancer Research and Clinical Oncology. The data on efficacy and safety of oral vs. intravenous Treosulfan administration in recurrent ovarian carcinoma are available online (http://link.springer.com/article/10.1007%2Fs00432-016-2307-0)

Further publications are available using the following link: Publications

iOMEDICO AG
Hanferstraße 28
D-79108 Freiburg

Phone: 0761 - 15 242 0
E-Mail: info@iomedico.com